http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9546159-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bddd83b0d4337e850c8a5e184ed0ec20 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-333 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-333 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06 |
| filingDate | 2013-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57e5593ad108b9403c584fdabf41b715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccee703882061ecb4ad27013186a5010 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_439a9ab5eb72fcd3bbd0b06da6c87e02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db5a659231cd62f337a84838414b0b7e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f46f83c4302f32a4ae853fdd10eb2f90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55bba3a7a1665b00dfe55c49ceaf0f66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f69d5a33bc691c04b61624898b4082f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd11ff673145c1cdaded439106d964dd |
| publicationDate | 2017-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-9546159-B2 |
| titleOfInvention | N-substituted 3,4-bis (catechol) pyrrole compounds, and the preparation and use thereof in the treatment of cancer |
| abstract | The present invention relates to a compound of formula (I) in which: -m is an integer from 0 to 3, preferably from 0 to 2; n is an integer from 0 to 3, preferably from 0 to 2; m+n≧1; EAG is an electro-attractive group chosen independently from among a halogen atom, an NO 2 , CF 3 , CCI 3 , CN, CO 2 H, (C═O)NR 2 , CH═NR, (C═S)OR, (C═O)SR, CS 2 R, SO 2 R, SO 2 NR 2 , SO 3 R, P(O)(OR) 2 , P(O)(R) 2 , B(OR) 2 group where R is a (C 1 -C 6 ) alkyl radical, a phenyl group or a hydrogen atom; A is a saturated or unsaturated, linear or branched hydrocarbon chain including 1 to 10 atoms of carbon; and R 1 and R 2 each represent independently from one another a hydrogen atom, a CO-(Ci-C6)-alkyl, (C 1 -C 6 ) alkyl, phenyl or phenyl-(C 1 -C 6 )-alkyl group, in which R 1 and R 2 form, together with the nitrogen atom they carry, a 5- to 15-member heterocycle, optionally substituted by a (C 1 -C 6 ) alkyl group; including its stereoisomers and the mixtures thereof, or a pharmaceutically acceptable salt of same. |
| priorityDate | 2012-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 227.